Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (15)
  • Antithrombotics (277)
    • Drug-Induced Thrombosis (28)
    • Prevention (44)
    • Reversal (22)
    • Treatment (252)
      • Apixaban (Eliquis) (96)
      • Aspirin (130)
      • Cangrelor (Kengreal) (4)
      • Clopidogrel (Plavix) (76)
      • Dabigatran (Pradaxa) (98)
      • Edoxaban (Savaysa) (39)
      • Low Molecular Weight Heparins (60)
      • Other (39)
      • Prasugrel (Effient) (40)
      • Rivaroxaban (Xarelto) (104)
      • Ticagrelor (Brilinta) (38)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (28)
      • Warfarin - Treatment (118)
  • Arrhythmias (127)
  • Blood Pressure (31)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (19)
  • CPR (6)
  • Dyslipidemia (164)
  • Endocarditis (21)
  • Heart Disease (74)
  • Heart Failure (149)
  • Hypertension (214)
  • Hypotension (26)
  • Ischemic Heart Disease/Acute Coronary Syndromes (234)
  • Myocardial Infarction (43)
  • Peripheral Vascular Disease (8)
  • Raynaud's (2)
  • Resources (675)
  • Stroke (114)
136 - 150 of 252 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: American Heart Association/American Stroke Association Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2015) September 2015
Article: Expect More Bleeding When Cangrelor Is Used September 2015
Article: Limit the Aspirin Dose to 81 mg in Stroke Patients September 2015
Article: Verify ICH Patients Get VTE Prophylaxis September 2015
Article: Don't Bridge Patients Most Afib Patients With Enoxaparin August 2015
PL Voices: When to Bridge Warfarin Patients August 2015
Article: Expect Less Use of IVC Filters With Anticoagulation July 2015
Commentary: IVC Filter Plus Anticoagulation vs Anticoagulation Alone for PE July 2015
Article: Verify CABG Patients are Started on an ACEI, Beta-Blocker, and Statin May 2015
Checklist: Post-CABG Pharmacotherapy Checklist May 2015
PL Voices: Medication Choices after Coronary Artery Bypass Graft (CABG) Surgery May 2015
Article: Use Actual Body Weight When Calculating Renal Function For Edoxaban March 2015
Toolbox: Reducing Hospital Readmissions March 2015
PL Voices: Role of the New Oral Anticoagulant, Savaysa (edoxaban) March 2015
Article: Use eGFR Instead of Cockcroft Gault for "Flozin" Dosing February 2015
  • « Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved